THE BST CASE

William Dobson ()

No 397, Staff Papers from University of Wisconsin Madison, AAE

Abstract: Recombinant Bovine Somatotropin (rBST) is a milk production enhancer, a product of industrial microbiology. First approved for commercial sale in the United States (U.S.) by the Food and Drug Administration (FDA) in 1994, rBST has been immersed in controversy since the early 1980s. Conflicts among major players with interests in rBST have shaped the product's image and influenced its use. Players with interests in the product include government agencies, Monsanto Corporation (the first firm approved to sell rBST), other firms seeking commercial approval to sell rBST, dairy farmers, and consumers.

Date: 1996-06
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://agecon.lib.umn.edu/wis/stpap397.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 500 Can't connect to agecon.lib.umn.edu:80 (No such host is known. )

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wop:wiaesp:397

Access Statistics for this paper

More papers in Staff Papers from University of Wisconsin Madison, AAE University of Wisconsin, Dept. of Agricultural and Applied Economics, 427 Lorch Street, Madison, WI 53706. Contact information at EDIRC.
Bibliographic data for series maintained by Thomas Krichel ().